A cancer vaccine built just for you Moderna and Merck just passed Phase 3 with a personalized mRNA cancer vaccine, and Moderna's stock jumped 177% in a day. Doctors sequence your tumor's DNA, find your specific mutations, then build a custom vaccine that trains your immune system to hunt only those cells. Paired with Keytruda to remove the immune system's brakes. Earlier trials cut recurrence risk by 49% and spread by 62%, now confirmed across 1,100+ melanoma patients. Moderna's already running trials for lung, bladder, and kidney cancer. Share this with someone who needs hope today. Save it, this is only the beginning. #CancerResearch #mRNA #Moderna #MedicalBreakthrough #anik